Introduction {#s1}
============

Laryngeal carcinoma, one of the most common types of cancer in the head and neck, accounts for 2.4% of new malignancies worldwide every year [@pone.0090181-Parkin1], [@pone.0090181-Lefebvre1]. This cancer is mainly squamous cell carcinoma, reflecting its origin from the squamous cells [@pone.0090181-Tomasino1]. In addition, it is approved that laryngeal carcinoma may spread by direct extension to adjacent structures, and frequently distant metastasis to the lung [@pone.0090181-Medina1], [@pone.0090181-Zvrko1]. Up to now, most patients of laryngeal cancer could retain laryngeal function after the therapy if the disease was detected at an early stage. But unfortunately, the fact is that the disease is often diagnosed at advanced stages because of the lack of reliable, early diagnostic biomarkers. Therefore, identification of biomarkers for early detection and prognosis is important and may in turn lead to more effective treatments using multiplex technologies.

Proteomics, a study of the complete protein complements of the cell, is the integration of biochemical, genetics, and proteomics data in the detection of biomarkers for early detection of cancers [@pone.0090181-Herrmann1]--[@pone.0090181-Johann1]. Proteomics is currently considered to be a powerful tool for global evaluation of protein expression, and has been widely applied. It has been suggested that analysis of the cancer proteome can be beneficial to understand not only the association between protein alterations and malignancy, but also the effect of molecular intracellular mislocalization in tumour initiation [@pone.0090181-Ma1]. Consistently, the development of increasingly high-throughput and sensitive mass spectroscopy-based proteomic techniques provides new opportunities to examine the physiology and pathophysiology of many biological samples. The two dimensional liquid chromatography tandem MS (2D LC-MS/MS) analysis is emerging as one of the more powerful quantitative proteomics methodologies in the search for tumour biomarkers [@pone.0090181-DeSouza1], [@pone.0090181-Zeng1]. For instance, in previous study the authors used 2D LC-MS/MS to identify 100 differentially expressed proteins from rheumatoid arthritis patients, and concluded that up-regulation of vasculature development related proteins and down-regulation of redox-related proteins in fibroblast-like synoviocytes were predominant factors that may contribute to the pathogenesis of rheumatoid arthritis [@pone.0090181-Wang1]. Moreover, using LC-MS/MS, Moon et al efficiently quantified the proteins of balding and non-balding dermal papilla cells (DPCs) from patients, and 128 up-regulated and 12 down-regulated proteins among 690 distinct proteins were identified in balding DPCs compared to non-balding DPCs [@pone.0090181-Moon1].

A number of studies using proteomics based on surface-enhanced laser desorption/ionization time-of-flight MS have identified the differential serum proteins in laryngeal carcinoma, leading to discovery of potential biomarkers for diagnosis or prognosis [@pone.0090181-Liu1], [@pone.0090181-Cheng1]. Although some proteomic studies on laryngeal carcinoma tissue have been reported [@pone.0090181-Li1]--[@pone.0090181-Ralhan1], there are no clinically established biomarkers available for early detection and therapeutic targets of this cancer. Therefore, to obtain more information, in the present study, 2D LC-MS/MS was performed to identify the differential proteins between laryngeal carcinoma tissue and corresponding adjacent noncancerous tissue, and then the bioinformatics analyses, including gene ontology (GO) analysis, and protein network analysis of different proteins were conducted. Subsequently, values of the four differential proteins (PFN1, NCL, CNDP2 and OGN) with expressional alterations were selectively validated by semiquantitative RT-PCR and Western blotting. Furthermore, we first time show that PFN1, NCL, CNDP2 and OGN may be potential diagnostic and therapeutic targets for laryngeal carcinoma, and demonstrate that PFN1 is involved in the migration of human squamous cells.

Methods {#s2}
=======

Patients {#s2a}
--------

Thirty-four laryngeal carcinoma tissues and corresponding adjacent noncancerous tissues were obtained from 34 patients who underwent surgical resection in Shanghai Changzheng Hospital, in accordance with approved human subject guidelines approved by the Scientific and Ethical Committee of Second Military Medical University. And an informed consent form was signed by the participants to proceed with the protocol research. All patients undergone resection and were not treated with neoadjuvant chemotherapy or radiotherapy. Two specimens were obtained from each patient, one from the centre of the tumor and the other of similar mass from remote areas (\>1 cm) adjacent to the cancerous regions. All these samples were taken by experienced surgeons and examined by experienced pathologists, frozen immediately in liquid nitrogen, and then frozen at −80°C until use. The clinical details of the patients are shown in [Table 1](#pone-0090181-t001){ref-type="table"}.
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###### Clinical characteristics of the patients

![](pone.0090181.t001){#pone-0090181-t001-1}

  Characteristic       No. of patients (%)
  ------------------- ---------------------
  Number of samples          N = 34
  Gender              
  Male                    32/34(94.12)
  Female                   2/34(5.88)
  Age (years)         
  Mean                      61.2±7.4
  Range                      38--75
  Clinical stage      
  I                        8/34(23.53)
  II                       6/34(17.65)
  III                     11/34(32.35)
  IV                       9/34(26.47)
  Tumor location      
  Glottic                 19/34(55.88)
  Supraglottic            11/34(32.35)
  Subglottic               2/34(5.88)
  Transglottic             2/34(5.88)

Protein sample preparation {#s2b}
--------------------------

Samples collected from ten cancer tissues and the corresponding adjacent noncancerous tissues groups were pooled, respectively. 2 mg samples were ground in liquid nitrogen. One milliliter of lysis buffer (7 M urea, 2 M thiourea, 1x Protease Inhibitor Cocktail (Roche Ltd. Basel, Switzerland)) was added to sample, followed by sonication on ice and centrifugation at 13 000 rpm for 15 min at 4°C. The supernatant was stored in small aliquots at −80°C and the protein concentration was determined using a modified Bradford method.

2D-LC-MS/MS {#s2c}
-----------

One hundred micrograms of protein were reduced with 1 mM DTT for 45 min at 60°C, and carbamidomethylated with 5 mM iodoacetamide for 45 min at room temperature in the dark. Alkylated proteins were diluted four times with deionized water, and then digested with sequencing grade modified trypsin (Promega) overnight. The protease/protein ratio was 1: 50. The resulting peptide mixture was acidified with TFA to pH = 3, and then was desalted using a 1.3 ml C18 solid phase extraction column (Sep-Pak Cartridge) (Waters Corpoation, Milford, USA). The peptides were dried using a vacuum centrifuge and then resuspended with loading buffer (5 mM Ammonium formate containing 5% acetonitrile, pH 3.0), separated and analyzed by two-dimensional (2D) strong cation-exchange (SCX)/reversed-phase (RP) nano-scale liquid chromatography/mass spectrometry (2D-nanoLC/MS). The experiments were performed on a Nano Aquity UPLC system (Waters Corporation, Milford, USA) connected to an LTQ Orbitrap XL mass spectrometer (Thermo Electron Corp., Bremen, Germany) equipped with an online nano-electrospray ion source (Michrom Bioresources, Auburn, USA).

A 180 µm×2.4 cm SCX column (Waters Corporation, Milford, USA), which was packed with a 5 µm Poly Sulfoethyl Aspartamide (PolyLC, Columbia, MD, USA) was used for the first dimension. To recover hydrophobic peptides still retained on the SCX column after a conventional salt step gradient, a RP step gradient from 5% to 50% acetonitrile (ACN) was applied to the SCX column. A 15 µl plug was injected each time to form the step gradients. At last, 1 M Ammonium formate (NH4FA) was used to clean the SCX colum once. The plugs were loaded onto the SCX column with a loading buffer at a 15 µl/min flow rate for 6 min. A 15 µl peptide sample was loaded onto the SCX column before the gradient plugs were injected. The eluted peptides were captured by a trap column (Waters) while salts were diverted to waste. The trap column (2 cm x 180 µm) was packed with a 5 µm Symmetry C18 material (Waters). The RP analytical column (15 cm x 100 µm) was packed with a 1.7 µm Bridged Ethyl Hybrid (BEH) C18 material (Waters), and was used for the second dimension separation.

The peptides on the RP analytical column were eluted with a three-step linear gradient. Starting from 5% B to 40% B in 40 min (A: water with 0.1% formic acid; B: ACN with 0.1% formic acid), increased to 80% B in 3 min, and then to 5% B in 2 min. The column was re-equilibrated at initial conditions for 15 min. The column flow rate was maintained at 500 nl/min and column temperature was maintained at 35°C. The electrospray voltage of 1.9 kV versus the inlet of the mass spectrometer was used.

LTQ Orbitrap XL mass spectrometer was operated in the data-dependent mode to switch automatically between MS and MS/MS acquisition. Survey full-scan MS spectra with two microscans (m/z 300--1800) were acquired in the Obitrap with a mass resolution of 60,000 at m/z 400, followed by ten sequential LTQ-MS/MS scans. Dynamic exclusion was used with two repeat counts, 10 s repeat duration, and 90 s exclusion duration. For MS/MS, precursor ions were activated using 35% normalized collision energy at the default activation q of 0.25.

The 2D-LC-MS/MS experiment was repeat three times for cancer sample and corresponding adjacent noncancerous sample, respectively.

Peptide sequencing and data analysis {#s2d}
------------------------------------

All MS/MS spectrums were identified by using SEQUEST \[v.28 (revision 12), Thermo Electron Corp.\] against the human UniProtKB/Swiss-Prot database (Release 2011_12_14, with 20249 entries), as previously described [@pone.0090181-Wang1]. To reduce false positive identification results, a decoy database containing the reverse sequences was appended to the database. The searching parameters were set up as follows: full trypsin cleavage with two missed cleavage was considered, the variable modification was oxidation of methionine, the peptide mass tolerance was 20 ppm, and the fragment ion tolerance was 1 Da. Trans Proteomic Pipeline software (revision 4.0)(Institute of Systems Biology, Seattle, WA) was then utilized to identify proteins based upon corresponding peptide sequences with ≥95% confidence. The peptides results were filtered by Peptide Prophet with a p-value over 0.90 and a Protein Prophet probability of 0.95 was used for the protein identification results. Employing the APEX tool to quantified the protein abundances, the abundances estimated by normalizing for the measured total protein concentration. The false positive rate of less than 1% was set for all peptide identifications.

Bioinformatics analysis {#s2e}
-----------------------

The original data were derived from analysis using APEX software. Differentially expressed proteins were screened using the 2-sample t-test (P\<0.05) and fold change (\>1.5 or \<0.667) method. All expression values of the differentially expressed proteins were first converted to a log form and then input as hierarchical clustering algorithms, where the Euclidean distance was used for distance and average for linkage for GO analysis. Differentially expressed genes were mapped to the appropriate GO database to calculate the number of genes at each node, using EASE software. The differentially expressed genes were classified according to bp (biologic process), cc (cellular component), and mf (molecular function) independently. In protein network analysis, interactions between genes in the range of the genomes analyzed were analyzed by downloading the pathway data in KEGG, MIPS, PubMed, MINT, Human Protein Reference Database (HPRD), BioGRID, Database of Interacting Proteins (DIP), and Reactome, using the BIND software package. Interrelationships between genes that had been reported in the literature were analyzed by co-citation calculation. The established gene network was able to directly reflect the interrelationships between genes at an overall level as well as the stability of the gene regulatory network.

Cell line and culture {#s2f}
---------------------

The human laryngeal carcinoma cell line Hep-2 was obtained from the cell bank of the Shanghai Institute of Cell Biology (Shanghai, China). The cells were maintained in RPMI 1640 upplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin sulphate, and 1 mM sodium pyruvate at 37°C in 5% CO~2~.

siRNAs preparation and transfection {#s2g}
-----------------------------------

The siRNAs were chemically synthesised by Shanghai GenePharma Co., Ltd.. The siRNA sequences for PFN1 were previously described [@pone.0090181-Ding1]: siRNA-PFN1: 5′- AGA AGG UGU CCA CGG UGG UUU -3′ (forward) and 5′- ACC ACC GUG GAC ACC UUC UUU -3′ (reverse). The negative control siRNAs were designed as follows: 5′-UAG CGA CUA AAC ACA UCA AUU-3′ (forward) and 5′-UUG AUG UGU UUA GUC GCU AUU-3′ (reverse). According to the manufacturer\'s specifications, the transfections of siRNA were carried out with Lipo2000 (Invitrogen) in 6-well plates. Until reached 50--70% confluence, the Hep-2 cells were transfected with 20 nM of siRNA for 6--12 h, and then replaced with the regular growth media. And cells were cultured for another 24--72 h before performing the experiments.

Semiquantitative RT-PCR {#s2h}
-----------------------

The total RNA was isolated from frozen tissues, and cells were extracted using TRIzol reagent (Takara). Two microgram of total RNA was used for cDNA synthesis using the RevertAidtm First Strand cDNA Synthesis Kit \#1622 (Fermentas) according to the manufacturer\'s instructions. The primer sequences and the expected sizes of PCR products were as follows: PFN1, 5′-ATC GAC AAC CTC ATG GCG GAC G-3′(forward) and 5′-TTG CCA ACC AGG ACA CCC ACC T-3′(reverse) (140 bp); NCL, 5′-GAA AGC GTT GGA ACT CAC-3′(forward) and 5′-AAG TGT TCT CGC ATC TCG-3′(reverse) (103 bp); CNDP2, 5′-AAC TCA GGC CCT CCC TCT GTT GT-3′(forward) and 5′-GCT CCA GGA AGT GAC TGC GGC-3′(reverse) (146 bp); OGN, 5′- GTT GAC ATT GAT GCT GTA CCA CCC-3′(forward) and 5′-GCT TGG GAG GAA GAA CTG GA-3′(reverse) (241 bp). GAPDH, 5′-CAA GGT CAT CCA TGA CAA CTT TG-3′ (forward) and 5′-GTC CAC CAC CCT GTT GCT GTA G-3′(reverse) (496 bp). The PCR conditions used for the amplification were as follows: 94°C for 5 min, then 30 cycles of 94°C for 20 s, 55--60°C for 20 s, and 72°C for 30 s, followed by 72°C for 10 min. The RT-PCR products were analysed on a 1% agarose gel and visualised with ethidium bromide staining. The GAPDH gene was used as a positive control to assess the cDNA quality.

Cell proliferation assay {#s2i}
------------------------

Cells (1×10^4^/ml) were plated in 96-well plates. At 24, 48, and 72 h post-transfection with PFN1 siRNA, the cell viability was determined by cell counting kit-8 (CCK-8) assay (Dojindo) according to the manufacture\'s protocol.

Transwell assay {#s2j}
---------------

Transwell assay was performed using polycarbonate transwell filters (Corning, 8 µm) as previously described [@pone.0090181-Zhang1]. Briefly, at 12 h posttransfection, a sample of 0.8×10^5^ cells were suspended in medium containing 1% FBS and added to the upper chamber. And the bottom chambers were filled with culture medium containing 20% FBS. After incubation for 24 h, the cells on the upper surface of the well were removed, and the cells on the lower surface were fixed in cold methanol and stained with 0.4% crystal violet (Sigma). For each experiment, the number of transmigrated cells in five random fields on the underside of the filter was counted and photographed, and three independent filters were analysed.

Western blotting {#s2k}
----------------

Whole-cell lysates were prepared from human tissue specimens and treated cells. For Western blotting analysis, equal amounts of proteins were separated using SDS-PAGE and transferred to a nitrocellulose membrane and then incubated with monoclonal antibody anti-PFN1 (Epitomics), monoclonal antibody anti-NCL (Santa Cruz), polyclonal antibody anti-CNDP2 (Proteintech), polyclonal antibody anti-OGN (Abgent), or monoclonal antibody anti-GAPDH (Bioworld) at 4°C overnight. The immunocomplexes were visualised using a horseradish peroxidase-conjugated antibody followed by a chemoluminescence reagent (Millipore) and detected on photographic film.

Statistical analysis {#s2l}
--------------------

The data was expressed as the mean ± SD. All calculations were performed with SPSS version 11.7. The statistical analyses were performed with Student\'s t-test and analysis of variance. Multiple groups comparison in other assays was performed by one-way ANOVA.

All P values were two tailed, and \<0.05 was considered statistically significant.

Results {#s3}
=======

Screening for differentially expressed proteins {#s3a}
-----------------------------------------------

Using APEX software, the original data were analyzed. Three independent experiments were performed in the laryngeal carcinoma (C) and the corresponding adjacent noncancerous (P) samples pools, respectively. According to the stringent criteria of having \>1 unique peptide per protein present and a false discovery rate of ≤5%, 1,738 proteins were identified from the two sample pools. Following the statistical Student\'s 2-sample t-test analysis and the Fold change (C/P) methods, 141 proteins were significantly up-regulated using the criteria of P\<0.05 and fold change \>1.5, and 140 proteins were significantly down-regulated by P\<0.05 and fold change \<0.667 ([Table 2](#pone-0090181-t002){ref-type="table"}). The expression values of the expressed proteins with significant difference were first converted to a log form and then input as hierarchical cluster algorithms. The results are shown in [Figure 1](#pone-0090181-g001){ref-type="fig"}.

![Hierarchical cluster analysis of the proteins expressed with statistically significant differences (P\<0.05, and fold change \>1.5 or \<0.667) in cancer tissue and paracancerous normal tissue from patients with laryngeal carcinoma.\
Three independent experiments were performed in cancer tissue (C1, C2, C3) and paracancerous normal tissue (P1, P2, P3).](pone.0090181.g001){#pone-0090181-g001}
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###### Differentially expressed proteins screened out compared the laryngeal carcinoma tissues (C) with the corresponding adjacent noncancerous tissues (P).

![](pone.0090181.t002){#pone-0090181-t002-2}

  Uniprot ID                                   Identified Proteins                                  Gene name   Fold change (C/P)   T test
  ------------ ----------------------------------------------------------------------------------- ----------- ------------------- ---------
  P29508                                            Serpin B3                                       SERPINB3          15.30         0.00677
  P53634                                     Dipeptidyl-peptidase 1                                   CTSC            13.70         0.00474
  P02792                                      Ferritin light chain                                     FTL            9.91          0.01259
  P04899                    Guanine nucleotide-binding protein G(i), alpha-2 subunit                  GNAI2           9.77          0.00089
  Q15181                                    Inorganic pyrophosphatase                                 PPA1            8.51          0.01315
  P19971                                     Thymidine phosphorylase                                  TYMP            8.06          0.00101
  P40227                                T-complex protein 1 subunit zeta                              CCT6A           7.86          0.00698
  P59998                           Actin-related protein 2/3 complex subunit 4                        ARPC4           7.64          0.00176
  P50552                              Vasodilator-stimulated phosphoprotein                           VASP            7.25          0.01336
  P13797                                            Plastin-3                                         PLS3            6.52          0.00256
  P09467                                  Fructose-1,6-bisphosphatase 1                               FBP1            6.37          0.04326
  O00299                            Chloride intracellular channel protein 1                          CLIC1           5.91          0.00516
  P52895                             Aldo-keto reductase family 1 member C2                          AKR1C2           5.82          0.0004
  O15533                                             Tapasin                                          TAPBP           5.81          0.01439
  Q16630                    Cleavage and polyadenylation specificity factor subunit 6                 CPSF6           5.76          0.04131
  P54578                            Ubiquitin carboxyl-terminal hydrolase 14                          USP14           5.47          0.01414
  P07737                                           Profilin-1                                         PFN1            5.20          0.00692
  P37837                                          Transaldolase                                      TALDO1           5.12          0.0124
  P31939                          Bifunctional purine biosynthesis protein PURH                       ATIC            5.05          0.01149
  P35637                                     RNA-binding protein FUS                                   FUS            5.02          0.01108
  P47929                                           Galectin-7                                        LGALS7           4.92          0.00664
  O00764                                        Pyridoxal kinase                                      PDXK            4.91          0.0044
  P23141                                    Liver carboxylesterase 1                                  CES1            4.86          0.01626
  A6NIZ1                                   Ras-related protein Rap-1b                                 RAP1B           4.78          0.00595
  P42224                  Signal transducer and activator of transcription 1-alpha/beta               STAT1           4.60          0.00168
  P55209                              Nucleosome assembly protein 1-like 1                           NAP1L1           4.41          0.02318
  O14979                         Heterogeneous nuclear ribonucleoprotein D-like                      HNRPDL           4.34          0.03791
  P11413                               Glucose-6-phosphate 1-dehydrogenase                            G6PD            4.30          0.01466
  P58107                                            Epiplakin                                         EPPK1           4.30          0.0157
  Q96AB3                   Isochorismatase domain-containing protein 2, mitochondrial                 ISOC2           4.26          0.01074
  P28838                                     Cytosol aminopeptidase                                   LAP3            4.25          0.01448
  O75569          Interferon-inducible double stranded RNA-dependent protein kinase activator A       PRKRA           4.21          0.04359
  Q12874                                  Splicing factor 3A subunit 3                                SF3A3           4.18          0.01359
  Q96HE7                                     ERO1-like protein alpha                                  ERO1L           4.09          0.02022
  O60664                         Mannose-6-phosphate receptor-binding protein 1                      M6PRBP1          3.91          0.00369
  P99999                                          Cytochrome c                                        CYCS            3.91          0.00451
  P19338                                            Nucleolin                                          NCL            3.90          0.02815
  O75874                          Isocitrate dehydrogenase \[NADP\] cytoplasmic                       IDH1            3.81          0.01901
  P23246                          Splicing factor, proline- and glutamine-rich                        SFPQ            3.67          0.00085
  Q01518                              Adenylyl cyclase-associated protein 1                           CAP1            3.61          0.01283
  Q07666           KH domain-containing, RNA-binding, signal transduction-associated protein 1       KHDRBS1          3.55          0.0109
  Q96KP4                               Cytosolic non-specific dipeptidase                             CNDP2           3.50          0.01266
  P30043                                        Flavin reductase                                      BLVRB           3.46          0.02879
  P05164                                         Myeloperoxidase                                       MPO            3.44          0.00316
  P36871                                      Phosphoglucomutase-1                                    PGM1            3.44          0.03173
  P50995                                           Annexin A11                                       ANXA11           3.43          0.03113
  P02786                                 Transferrin receptor protein 1                               TFRC            3.40          0.04239
  Q16658                                             Fascin                                           FSCN1           3.36          0.01824
  P63104                                    14-3-3 protein zeta/delta                                 YWHAZ           3.35          0.01256
  P00491                                 Purine nucleoside phosphorylase                               NP             3.32          0.00487
  Q9UNM6                         26S proteasome non-ATPase regulatory subunit 13                     PSMD13           3.28          0.04739
  P68104                            Putative elongation factor 1-alpha-like 3                        EEF1AL3          3.28          0.00105
  Q13347                      Eukaryotic translation initiation factor 3 subunit I                    EIF3I           3.20          0.01014
  Q96FQ6                                        Protein S100-A16                                     S100A16          3.17          0.01151
  P52565                                Rho GDP-dissociation inhibitor 1                             ARHGDIA          3.15          0.00299
  Q99715                                   Collagen alpha-1(XII) chain                               COL12A1          3.12          0.02148
  P29401                                          Transketolase                                        TKT            3.09          0.00809
  P53582                                   Methionine aminopeptidase 1                               METAP1           3.08          0.00304
  P52209                        6-phosphogluconate dehydrogenase, decarboxylating                      PGD            2.96          0.03408
  P17096                             High mobility group protein HMG-I/HMG-Y                          HMGA1           2.95          0.02965
  P13693                            Translationally-controlled tumor protein                          TPT1            2.88          0.02137
  Q01469                              Fatty acid-binding protein, epidermal                           FABP5           2.86          0.03051
  Q14974                                     Importin subunit beta-1                                  KPNB1           2.84          0.01796
  P31949                                        Protein S100-A11                                     S100A11          2.82          0.01872
  P02144                                            Myoglobin                                          MB             2.81          0.01049
  Q16543                                    Hsp90 co-chaperone Cdc37                                  CDC37           2.77          0.01228
  P50914                                    60S ribosomal protein L14                                 RPL14           2.75          0.00198
  Q9Y490                                             Talin-1                                          TLN1            2.67          0.0068
  P06733                                          Alpha-enolase                                       ENO1            2.64          0.01238
  P24821                                            Tenascin                                           TNC            2.63          0.01489
  P37802                                          Transgelin-2                                       TAGLN2           2.57          0.03438
  P61160                                     Actin-related protein 2                                  ACTR2           2.57          0.00239
  P30838                         Aldehyde dehydrogenase, dimeric NADP-preferring                     ALDH3A1          2.56          0.03337
  P13010                             ATP-dependent DNA helicase 2 subunit 2                           XRCC5           2.55          0.00755
  P30085                                         UMP-CMP kinase                                       CMPK1           2.55          0.0115
  Q9UN86                         Ras GTPase-activating protein-binding protein 2                      G3BP2           2.55          0.01204
  P18206                                            Vinculin                                           VCL            2.53          0.02193
  Q92616                                  Translational activator GCN1                               GCN1L1           2.53          0.02057
  P05198                      Eukaryotic translation initiation factor 2 subunit 1                   EIF2S1           2.50          0.03971
  O00303                      Eukaryotic translation initiation factor 3 subunit F                    EIF3F           2.49          0.01838
  P09110                              3-ketoacyl-CoA thiolase, peroxisomal                            ACAA1           2.49          0.00319
  P09651                           Heterogeneous nuclear ribonucleoprotein A1                        HNRNPA1          2.49          0.04643
  P63241                          Eukaryotic translation initiation factor 5A-1                       EIF5A           2.48          0.00699
  P16401                                          Histone H1.5                                      HIST1H1B          2.47          0.02978
  P60842                                Eukaryotic initiation factor 4A-I                            EIF4A1           2.47          0.02891
  P04406                            Glyceraldehyde-3-phosphate dehydrogenase                          GAPDH           2.43          0.01183
  P07195                                 L-lactate dehydrogenase B chain                              LDHB            2.41          0.0067
  Q12931                            Heat shock protein 75 kDa, mitochondrial                          TRAP1           2.40          0.00724
  Q99832                                 T-complex protein 1 subunit eta                              CCT7            2.40          0.00158
  P18669                                    Phosphoglycerate mutase 1                                 PGAM1           2.39          0.02256
  Q07960                                 Rho GTPase-activating protein 1                             ARHGAP1          2.37          0.00799
  P60174                                    Triosephosphate isomerase                                 TPI1            2.36          0.00203
  P13639                                       Elongation factor 2                                    EEF2            2.35          0.00292
  P26641                                    Elongation factor 1-gamma                                 EEF1G           2.34          0.00212
  Q86VP6                          Cullin-associated NEDD8-dissociated protein 1                       CAND1           2.29          0.00207
  P38606                            V-type proton ATPase catalytic subunit A                         ATP6V1A          2.26          0.03249
  Q15691                      Microtubule-associated protein RP/EB family member 1                   MAPRE1           2.23          0.03292
  P62244                                   40S ribosomal protein S15a                                RPS15A           2.19          0.01589
  P69905                                    Hemoglobin subunit alpha                                  HBA1            2.19          0.00953
  Q07021              Complement component 1 Q subcomponent-binding protein, mitochondrial            C1QBP           2.17          0.03131
  P02751                                           Fibronectin                                         FN1            2.16          0.01678
  P09211                                   Glutathione S-transferase P                                GSTP1           2.15          0.02025
  P23381                            Tryptophanyl-tRNA synthetase, cytoplasmic                         WARS            2.13          0.00901
  P26599                             Polypyrimidine tract-binding protein 1                           PTBP1           2.13          0.03262
  P29692                                    Elongation factor 1-delta                                 EEF1D           2.13          0.0437
  P14618                                 Pyruvate kinase isozymes M1/M2                               PKM2            2.13          0.00143
  P11940                                 Polyadenylate-binding protein 1                             PABPC1           2.12          0.02495
  P13667                                 Protein disulfide-isomerase A4                               PDIA4           2.11          0.01605
  P13796                                            Plastin-2                                         LCP1            2.11          0.00619
  P09960                                    Leukotriene A-4 hydrolase                                 LTA4H           2.10          0.01662
  Q15149                                            Plectin-1                                         PLEC1           2.07          0.00424
  Q13011                   Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial                 ECH1            2.06          0.01475
  P04632                                     Calpain small subunit 1                                 CAPNS1           2.06          0.03241
  P00918                                      Carbonic anhydrase 2                                     CA2            2.05          0.0467
  P40616                             ADP-ribosylation factor-like protein 1                           ARL1            2.02          0.01116
  P40939                        Trifunctional enzyme subunit alpha, mitochondrial                     HADHA           2.01          0.00595
  P23528                                            Cofilin-1                                         CFL1            2.01          0.02903
  Q8NBS9                             Thioredoxin domain-containing protein 5                         TXNDC5           1.93          0.00024
  P52566                                Rho GDP-dissociation inhibitor 2                             ARHGDIB          1.92          0.04385
  Q14103                           Heterogeneous nuclear ribonucleoprotein D0                        HNRNPD           1.92          0.03422
  Q08211                                  ATP-dependent RNA helicase A                                DHX9            1.91          0.01272
  Q8TE68               Epidermal growth factor receptor kinase substrate 8-like protein 1            EPS8L1           1.91          0.02329
  O15372                      Eukaryotic translation initiation factor 3 subunit H                    EIF3H           1.85          0.01438
  P07858                                           Cathepsin B                                        CTSB            1.84          0.00487
  P17655                                   Calpain-2 catalytic subunit                                CAPN2           1.84          0.03102
  P10809                            60 kDa heat shock protein, mitochondrial                          HSPD1           1.82          0.02513
  P51970                 NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 8              NDUFA8           1.82          0.04023
  P14625                                           Endoplasmin                                       HSP90B1          1.82          0.0194
  P30153        Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform    PPP2R1A          1.81          0.0417
  O75955                                           Flotillin-1                                        FLOT1           1.78          0.00694
  Q02878                                    60S ribosomal protein L6                                  RPL6            1.78          0.01691
  O75083                                 WD repeat-containing protein 1                               WDR1            1.75          0.01675
  P12268                            Inosine-5′-monophosphate dehydrogenase 2                         IMPDH2           1.75          0.0418
  P24158                                          Myeloblastin                                        PRTN3           1.74          0.01096
  Q7KZF4                       Staphylococcal nuclease domain-containing protein 1                    SND1            1.73          0.00169
  P00558                                    Phosphoglycerate kinase 1                                 PGK1            1.72          0.00095
  P60660                                   Myosin light polypeptide 6                                 MYL6            1.70          0.02066
  Q13200                         26S proteasome non-ATPase regulatory subunit 2                       PSMD2           1.69          0.04337
  P61019                                   Ras-related protein Rab-2A                                 RAB2A           1.65          0.0369
  Q92597                                          Protein NDRG1                                       NDRG1           1.61          0.00689
  P02768                                          Serum albumin                                        ALB            1.57          0.00957
  O00231                         26S proteasome non-ATPase regulatory subunit 11                     PSMD11           1.56          0.02677
  Q9P2E9                                   Ribosome-binding protein 1                                 RRBP1           0.66          0.02565
  P98160              Basement membrane-specific heparan sulfate proteoglycan core protein            HSPG2           0.65          0.02063
  P06576                            ATP synthase subunit beta, mitochondrial                          ATP5B           0.65          0.04632
  Q9ULV4                                           Coronin-1C                                        CORO1C           0.58          0.04756
  P29966                          Myristoylated alanine-rich C-kinase substrate                      MARCKS           0.58          0.01746
  P62861                                    40S ribosomal protein S30                                  FAU            0.57          0.00947
  P06396                                            Gelsolin                                           GSN            0.56          0.04161
  P02652                                       Apolipoprotein A-II                                    APOA2           0.56           0.04
  P02763                                   Alpha-1-acid glycoprotein 1                                ORM1            0.55          0.00937
  P31146                                           Coronin-1A                                        CORO1A           0.55           0.034
  P11047                                     Laminin subunit gamma-1                                  LAMC1           0.54          0.02215
  P20700                                            Lamin-B1                                          LMNB1           0.53          0.03269
  P10412                                          Histone H1.2                                      HIST1H1C          0.53          0.01299
  P14866                            Heterogeneous nuclear ribonucleoprotein L                        HNRNPL           0.53          0.00906
  P09622                           Dihydrolipoyl dehydrogenase, mitochondrial                          DLD            0.53          0.00322
  P14923                                      Junction plakoglobin                                     JUP            0.52          0.01465
  O95994                               Anterior gradient protein 2 homolog                            AGR2            0.52          0.04294
  P49748                 Very long-chain specific acyl-CoA dehydrogenase, mitochondrial              ACADVL           0.52          0.03597
  P08603                                       Complement factor H                                     CFH            0.52          0.01851
  Q16891                              Mitochondrial inner membrane protein                            IMMT            0.51          0.03273
  P05091                              Aldehyde dehydrogenase, mitochondrial                           ALDH2           0.51          0.02974
  P00505                            Aspartate aminotransferase, mitochondrial                         GOT2            0.50          0.00699
  Q13813                                   Spectrin alpha chain, brain                               SPTAN1           0.50          0.00471
  P11216                               Glycogen phosphorylase, brain form                             PYGB            0.50          0.02901
  Q6YN16                           Hydroxysteroid dehydrogenase-like protein 2                        HSDL2           0.50          0.00185
  P10155                                60 kDa SS-A/Ro ribonucleoprotein                             TROVE2           0.50          0.03947
  P30084                               Enoyl-CoA hydratase, mitochondrial                             ECHS1           0.50          0.0033
  P19823                          Inter-alpha-trypsin inhibitor heavy chain H2                        ITIH2           0.49          0.02225
  P30048                     Thioredoxin-dependent peroxide reductase, mitochondrial                  PRDX3           0.49          0.01532
  P08727                                 Keratin, type I cytoskeletal 19                              KRT19           0.49          0.01893
  Q9UHG3                                    Prenylcysteine oxidase 1                                 PCYOX1           0.49          0.02023
  P27635                                    60S ribosomal protein L10                                 RPL10           0.49          0.02615
  P27824                                            Calnexin                                          CANX            0.49          0.04302
  Q15582                      Transforming growth factor-beta-induced protein ig-h3                   TGFBI           0.49          0.00143
  P01024                                          Complement C3                                        C3             0.49          0.00256
  P00488                                 Coagulation factor XIII A chain                              F13A1           0.49          0.01016
  P02747                              Complement C1q subcomponent subunit C                           C1QC            0.48          0.04694
  Q01082                                  Spectrin beta chain, brain 1                               SPTBN1           0.48          0.01722
  P39656          Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit       DDOST           0.48          0.04726
  P04080                                           Cystatin-B                                         CSTB            0.47          0.04055
  P01023                                      Alpha-2-macroglobulin                                    A2M            0.47          0.02189
  Q9NSE4                            Isoleucyl-tRNA synthetase, mitochondrial                          IARS2           0.46          0.04337
  P36269                                   Gamma-glutamyltransferase 5                                GGT5            0.46          0.00259
  P21810                                            Biglycan                                           BGN            0.46          0.00989
  P31040                   Succinate dehydrogenase flavoprotein subunit, mitochondrial                SDHA            0.45          0.00591
  P02788                                        Lactotransferrin                                       LTF            0.45          0.02393
  P62158                                           Calmodulin                                         CALM1           0.44          0.01293
  P01857                                    Ig gamma-1 chain C region                                 IGHG1           0.43          0.00036
  P22695                        Cytochrome b-c1 complex subunit 2, mitochondrial                     UQCRC2           0.43          0.00169
  P46781                                    40S ribosomal protein S9                                  RPS9            0.43          0.04449
  Q02218                    2-oxoglutarate dehydrogenase E1 component, mitochondrial                  OGDH            0.43          0.01132
  P24539                              ATP synthase subunit b, mitochondrial                          ATP5F1           0.42          0.01379
  P17931                                           Galectin-3                                        LGALS3           0.42          0.00253
  P01009                                       Alpha-1-antitrypsin                                  SERPINA1          0.41          0.00246
  P00738                                           Haptoglobin                                         HP             0.41          0.0076
  P62280                                    40S ribosomal protein S11                                 RPS11           0.41          0.04435
  P43304                        Glycerol-3-phosphate dehydrogenase, mitochondrial                     GPD2            0.41          0.02182
  O60716                                         Catenin delta-1                                     CTNND1           0.41          0.01993
  Q96IU4                            Abhydrolase domain-containing protein 14B                        ABHD14B          0.40          0.04326
  Q14152                      Eukaryotic translation initiation factor 3 subunit A                    EIF3A           0.40          0.04596
  P51888                                            Prolargin                                         PRELP           0.40          0.0218
  P02511                                    Alpha-crystallin B chain                                  CRYAB           0.40          0.02841
  Q8NCW5                               Apolipoprotein A-I-binding protein                            APOA1BP          0.39           0.014
  P84098                                    60S ribosomal protein L19                                 RPL19           0.39          0.01034
  O75306                     NADH dehydrogenase iron-sulfur protein 2, mitochondrial                 NDUFS2           0.39          0.0012
  P07099                                       Epoxide hydrolase 1                                    EPHX1           0.39          0.01386
  P49755                        Transmembrane emp24 domain-containing protein 10                     TMED10           0.39          0.03179
  P60709                                      Actin, cytoplasmic 2                                    ACTG1           0.39          0.00425
  P00450                                          Ceruloplasmin                                        CP             0.38          0.01124
  P21796                       Voltage-dependent anion-selective channel protein 1                    VDAC1           0.38          0.02369
  P02545                                            Lamin-A/C                                         LMNA            0.38          0.00148
  P39059                                   Collagen alpha-1(XV) chain                                COL15A1          0.38          0.02395
  P63167                                Dynein light chain 1, cytoplasmic                            DYNLL1           0.38          0.00646
  Q14134                             Tripartite motif-containing protein 29                          TRIM29           0.38          0.00844
  P51571                           Translocon-associated protein subunit delta                        SSR4            0.37          0.02087
  Q9UN36                                          Protein NDRG2                                       NDRG2           0.37          0.02335
  P01834                                     Ig kappa chain C region                                  IGKC            0.37          0.03372
  Q02790                                     FK506-binding protein 4                                  FKBP4           0.37          0.01019
  P04217                                      Alpha-1B-glycoprotein                                   A1BG            0.36          0.02191
  Q9BS26                             Thioredoxin domain-containing protein 4                         TXNDC4           0.36          0.02078
  P30040                               Endoplasmic reticulum protein ERp29                            ERP29           0.35          0.0485
  P12532                            Creatine kinase, ubiquitous mitochondrial                        CKMT1A           0.35          0.02472
  Q08380                                   Galectin-3-binding protein                               LGALS3BP          0.35          0.00749
  P30049                            ATP synthase subunit delta, mitochondrial                         ATP5D           0.33          0.01374
  P63244                    Guanine nucleotide-binding protein subunit beta-2-like 1                 GNB2L1           0.33           0.002
  P35232                                           Prohibitin                                          PHB            0.33          0.01226
  Q01081                               Splicing factor U2AF 35 kDa subunit                            U2AF1           0.31          0.01422
  Q9UQ80                              Proliferation-associated protein 2G4                            PA2G4           0.31          0.01201
  P02730                                 Band 3 anion transport protein                              SLC4A1           0.30          0.01198
  P31930                        Cytochrome b-c1 complex subunit 1, mitochondrial                     UQCRC1           0.29          0.00459
  O75367                                    Core histone macro-H2A.1                                  H2AFY           0.29          0.00555
  P11177                 Pyruvate dehydrogenase E1 component subunit beta, mitochondrial              PDHB            0.29          0.04049
  P24752                           Acetyl-CoA acetyltransferase, mitochondrial                        ACAT1           0.28          0.01184
  P08294                          Extracellular superoxide dismutase \[Cu-Zn\]                        SOD3            0.27          0.04222
  Q05707                                   Collagen alpha-1(XIV) chain                               COL14A1          0.27          0.00088
  P62826                                 GTP-binding nuclear protein Ran                               RAN            0.27          0.03551
  Q99623                                          Prohibitin-2                                        PHB2            0.27          0.00683
  P04844            Dolichyl-diphosphooligosaccharide---protein glycosyltransferase subunit 2         RPN2            0.26          0.02265
  Q12907                            Vesicular integral-membrane protein VIP36                         LMAN2           0.26          0.02661
  P04181                            Ornithine aminotransferase, mitochondrial                          OAT            0.26          0.01802
  P62750                                   60S ribosomal protein L23a                                RPL23A           0.25          0.0077
  P06732                                     Creatine kinase M-type                                    CKM            0.25          0.02901
  P14927                                Cytochrome b-c1 complex subunit 7                             UQCRB           0.25          0.04749
  P51884                                             Lumican                                           LUM            0.25          0.0166
  Q9UH99                                    Protein unc-84 homolog B                                 UNC84B           0.24          0.01415
  P00403                                 Cytochrome c oxidase subunit 2                              MT-CO2           0.24          0.00441
  P02675                                      Fibrinogen beta chain                                    FGB            0.24          0.01004
  P49257                                        Protein ERGIC-53                                      LMAN1           0.23          0.00243
  Q03252                                            Lamin-B2                                          LMNB2           0.23          0.00382
  P58546                                           Myotrophin                                         MTPN            0.23          0.03507
  P32969                                    60S ribosomal protein L9                                  RPL9            0.22          0.03767
  O95299         NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 10, mitochondrial      NDUFA10          0.21          0.02844
  Q16795          NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 9, mitochondrial      NDUFA9           0.21          0.01163
  P04843            Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1          RPN1            0.20          0.00436
  Q8TDL5              Long palate, lung and nasal epithelium carcinoma-associated protein 1          LPLUNC1          0.20          0.02273
  P20774                                             Mimecan                                           OGN            0.20          0.03045
  P02679                                     Fibrinogen gamma chain                                    FGG            0.19          0.00129
  P48047                              ATP synthase subunit O, mitochondrial                           ATP5O           0.19          0.01449
  P62841                                    40S ribosomal protein S15                                 RPS15           0.19          0.02324
  Q92817                                           Envoplakin                                         EVPL            0.19          0.00422
  P09493                                    Tropomyosin alpha-1 chain                                 TPM1            0.19          0.01514
  P19652                                   Alpha-1-acid glycoprotein 2                                ORM2            0.18          0.00543
  Q9UIJ7                            GTP:AMP phosphotransferase mitochondrial                           AK3            0.18          0.01683
  P00367                            Glutamate dehydrogenase 1, mitochondrial                          GLUD1           0.18          0.01563
  P10916               Myosin regulatory light chain 2, ventricular/cardiac muscle isoform            MYL2            0.18          0.00277
  P00387                                 NADH-cytochrome b5 reductase 3                              CYB5R3           0.17          0.00535
  Q9UI09                        NADH dehydrogenase 1 alpha subcomplex subunit 12                     NDUFA12          0.17          0.00843
  P32322                       Pyrroline-5-carboxylate reductase 1, mitochondrial                     PYCR1           0.17          0.00997
  P45880                       Voltage-dependent anion-selective channel protein 2                    VDAC2           0.17          0.00812
  Q9BSJ8                                    Extended synaptotagmin-1                                 FAM62A           0.17          0.02282
  P12883                                            Myosin-7                                          MYH7            0.15          0.04314
  P07585                                             Decorin                                           DCN            0.15          0.00903
  P45378                                Troponin T, fast skeletal muscle                              TNNT3           0.14          0.03654
  Q07954                      Prolow-density lipoprotein receptor-related protein 1                   LRP1            0.13          0.01165
  P61626                                           Lysozyme C                                          LYZ            0.13          0.00319
  P20618                                 Proteasome subunit beta type-1                               PSMB1           0.11          0.03038
  Q96A32                    Myosin regulatory light chain 2, skeletal muscle isoform                  MYLPF           0.09          0.00292
  P01876                                    Ig alpha-1 chain C region                                 IGHA1           0.07          0.00055
  Q9BXN1                                             Asporin                                          ASPN            0.07          0.00292
  P35749                                            Myosin-11                                         MYH11           0.06          0.03254

GO analysis of the proteins with significant difference in expression {#s3b}
---------------------------------------------------------------------

To get more insight on the biological significance of the differentially expressed proteins in human laryngeal carcinoma, GO analysis was conducted on 281 differentially expressed proteins ([Figure 2](#pone-0090181-g002){ref-type="fig"}). According to biologic process analysis, it showed that each group was enriched with the proteins of different functions, suggesting that the differentially expressed proteins may play a distinctive role in human laryngeal carcinogenesis by these signaling pathways.

![Gene ontology analysis of differentially expressed proteins classified according to biologic process.](pone.0090181.g002){#pone-0090181-g002}

Analysis of the differential protein network {#s3c}
--------------------------------------------

To identify the potential interrelationships between proteins expressed with significant difference, a protein--protein interaction network was built up with Pajek software. Consistently, the differential protein network was established by integrating three different types of interaction: 1) protein--protein interactions obtained in well established high-throughput experiments such as yeast 2-hybrid experiments; 2) gene interactions reported in the literature; and 3) protein interaction, gene regulation, and protein decoration. The results are shown in [Figure 3](#pone-0090181-g003){ref-type="fig"}. These proteins may have important roles in laryngeal carcinoma oncogenesis and progression, and their presence in this network diagram confirms the relevance of the differentially expressed proteins data set and their association to laryngeal carcinoma, in some way.

![Protein network analysis.\
The protein--protein interaction network of differential proteins is shown.](pone.0090181.g003){#pone-0090181-g003}

Validation of differentially expressed proteins indentified by proteomics {#s3d}
-------------------------------------------------------------------------

Next, semiquantitative RT-PCR was performed to detect the mRNA levels of PFN1, NCL, CNDP2 and OGN in 8 cases of paired laryngeal carcinoma tissues. As shown in [Figure 4A](#pone-0090181-g004){ref-type="fig"}, in most cases, PFN1, NCL and CNDP2 exerted an increased mRNA expression, while OGN displayed a decreased level in the carcinoma tissues compared with the adjacent normal tissue. The protein expression level of the four selected molecules was further investigated with 24 paired cases of laryngeal carcinoma and non-cancer tissue sections using Western blotting. And the results revealed that the expression of PFN1, NCL, and CNDP2 was elevated and that of OGN was reduced in laryngeal carcinoma tissue compared with the adjacent normal tissue ([Figure 4B](#pone-0090181-g004){ref-type="fig"}). Thus, these results validate the differentially expressed proteins indentified by the proteomics.

![Validation of differentially expressed proteins in laryngeal carcinoma tissue and the adjacent normal tissue by semiquantitative RT-PCR and Western blotting.\
(A) The representative image of mRNA levels of PFN1, NCL, CNDP2 and OGN between laryngeal carcinoma tissue and their corresponding normal tissue in 8 cases of tissues measured by semiquantitative RT-PCR. (B) The representative result of Western blotting show the expressions of PFN1, NCL, CNDP2 and OGN in the laryngeal carcinoma tissue and the adjacent normal tissue, respectively. Histograms are representative the relative abundance of proteins mean from 24 cases of tissues. (\*\*P\<0.01 by One-way ANOVA).](pone.0090181.g004){#pone-0090181-g004}

PFN1 silencing inhibits the proliferation and metastasis of the human laryngeal carcinoma Hep-2 cells {#s3e}
-----------------------------------------------------------------------------------------------------

To know whether down-regulation of PFN1 is involved in laryngeal carcinoma carcinogenesis, Hep-2 cells were transfected with siRNA to specifically target PFN1 or negative control siRNA, and then the proliferation and metastasis of the transfected cells were measured. The transfection efficiency was confirmed by semiquantitative RT-PCR and Western blotting. The data showed that PFN1 expression in the siRNA-PFN1 group was reduced significantly at both the mRNA (24 h) and protein (48 h) levels when compared to the levels in the negative control siRNA and untreated control groups ([Figure 5A](#pone-0090181-g005){ref-type="fig"}). Next, the proliferation of siRNA-transfected Hep-2 cells was determined by CCK-8 assay. As shown in [Figure 5B](#pone-0090181-g005){ref-type="fig"}, within 48 hours, the percentages of viable cells were not significantly different in the PFN1 siRNA group when compared to the negative control siRNA and untreated control groups. And the cells of PFN1 siRNA group showed a significantly decreased proliferation at 72 h time points. Additionally, transwell assay was performed to further determine whether the downregulation of PFN1 could influence the migration ability of Hep-2 cells. As expectably, the numbers of cells in the siRNA-PFN1 group that migrated to the lower surfaces of the transwells were reduced in comparison to those in the negative control siRNA and untreated control groups ([Figure 5C and D](#pone-0090181-g005){ref-type="fig"}). These results indicate that PFN1 silencing affects the proliferation and migration ability of Hep-2 cells.

![Effects of PFN1 silencing on the proliferation and metastasis of Hep-2 cells.\
(A) The mRNA (24 h) and protein (48 h) expression of PFN1 after specific siRNA transfection in Hep-2 cells. The levels of mRNA and protein were determined by semiquantitative RT-PCR and Western blotting, respectively. (B) The cell viability of Hep-2 cells harvested 24, 48, and 72 h post-transfection after treatment with siPFN1. The optical density (OD) represents the proliferative characters of the treated cells. (C) The directed migratory capacities of Hep-2 cells after the siPFN1 transfected for 24 h were evaluated using a Transwell migration study. Images of cells on the undersurface of a filter are shown. Bar, 20 µm. (D) The number of cells per field in control and treated cells is shown. Values are the mean ± SD from three independent experiments. \*\*P\<0.01.](pone.0090181.g005){#pone-0090181-g005}

Discussion {#s4}
==========

Previous proteomics study using 2D-MS identified the differential proteins in laryngeal carcinoma tissue [@pone.0090181-Sewell1], few candidate proteins were detectable because of low resolution, and most of the differentially expressed proteins detected were high-abundance proteins. In addition, using SELDI-TOF-MS method to identify the proteomic shift in laryngeal carcinoma serum, Cheng et al and Liu group reported different findings and conclusions that few proteins were found to vary in concert, and the discrepancies might be due to their technical problems such as varying ability of mass spectrometry to identify a particular protein [@pone.0090181-Liu1], [@pone.0090181-Cheng1]. Thus, successful application of proteomic technologies to biomedical and clinical research is leading to the discovery of disease-specific biomarkers for diagnosis and treatment monitoring, providing insight into the underlying pathologies and allowing identification of novel therapeutic targets [@pone.0090181-Wang1]. In the current study, we used 2 chromatographic methods coupled with MS to detect differentially expressed proteins and thereby greatly raised the number of detectable proteins. The 2D LC-MS/MS analysis performed in this study led to the identification of 1738 proteins, among which 281 were differentially expressed with significance between the laryngeal carcinoma tissues and the corresponding adjacent noncancerous tissues. Of these, 141 proteins were upregulated, and the remaining 140 proteins were downregulated. To get more insight on the biological significance of the differentially expressed proteins in laryngeal carcinoma process, hierarchical cluster, gene ontology and protein network analysis were performed on 281 differential proteins. Stage-specific and coregulated expression profiles of the differentially expressed proteins were displayed in the hierarchical cluster analysis. GO analysis revealed that each functional group may play a distinctive role during laryngeal carcinoma carcinogenesis. Additionally, the network diagram confirmed the relevance of the differentially expressed proteins provided a handle by which to identify upstream activators and downstream effectors.

Considerable proteins, such as YWHAZ, S100-A11, glutathione S-transferase, alpha-enolase, flavin reductase, fascin, and carbonic anhydrase, have been reported to be associated with laryngeal carcinoma in previous proteomics studies but without clinical validation and in-depth functional research [@pone.0090181-Sewell1], [@pone.0090181-Ralhan1]. However, in our present study, four of the altered expressed proteins with different subcellular localization, such as PFN1: extracellular, NCL: nucleolus, nucleus and cytoplasm, CNDP2: cytoplasm, and OGN: extracellular, have been observed to be differentially expressed in cancers from other origins but not previously in laryngeal carcinoma [@pone.0090181-Wu1]--[@pone.0090181-Orr1]. Meanwhile, these candidates have been proved to be involved in multiple cellular pathways related to carcinogenesis, including proliferation, differentiation, apoptosis, migration, and invasion. Thus, the expression of PFN1, NCL, CNDP2 and OGN were further investigated employing a large collection of human laryngeal carcinoma tissues. Noteworthy, the effects of PFN1 in the proliferation and migration of human squamous cells were also analysed.

Profilin-1(PFN1), as an important actin-binding protein and ubiquitously expressed profilin isoform, has been considered as an essential control element for actin polymerization by virtue of its ability to funnel actin monomers (G-actin) to the growing filament and interact with almost all major protein families, which involved in nucleation and/or elongation of actin filaments [@pone.0090181-Witke1]. Deregulation of PFN1 has been reported in various adenocarcinomas (breast, pancreas, hepatic, and gastric), and indicating that the molecule may function as a tumor-suppressor gene [@pone.0090181-Oien1]--[@pone.0090181-Gronborg1]. Especially, PFN1 plays crucial roles in metastasis and carcinogenesis of mammary epithelial cells by regulating membrane protrusion, motility, and invasion [@pone.0090181-Mouneimne1]. To know whether down-regulation of PFN1 is involved in laryngeal carcinoma carcinogenesis, we knocked down PFN1 in human laryngeal carcinoma cells Hep-2, and then detected whether PFN1 knockdown decreased the proliferation and metastasis of Hep-2 cells. The data showed that PFN1 silencing inhibited the proliferation and affected the migration ability of Hep-2 cells, demonstrating that PFN1 plays an important role in human laryngeal carcinoma carcinogenesis. To our knowledge, this is the first report to establish a correlation between PFN1 down-regulation and carcinogenesis of human laryngeal carcinoma, and PFN1 as a potential biomarker for early detection of this cancer.

Nucleolin (NCL) is another protein found overexpressed in laryngeal carcinoma. As a multifunctional phosphoprotein, NCL has a bipartite nuclear localization signal sequence and binds RNA through its RNA recognition motifs [@pone.0090181-Tajrishi1]. It has been shown to be up-regulated in highly proliferative cells and regulated many aspects of DNA and RNA metabolism, chromatin structure, rRNA maturation, cytokinesis, nucleogenesis, cell proliferation and growth [@pone.0090181-Angelov1], [@pone.0090181-Mi1]. Further, the expression of NCL was reported to be increased in pancreatic ductal adenocarcinoma and the overexpression of the protein was found in other human cancers such as gliomas, melanoma, and non-small cell lung cancer [@pone.0090181-Peng2]--[@pone.0090181-Zhao1]. Similarly, our semiquantitative RT-PCR and Western blotting results confirmed on a larger series of specimens the increased expression of NCL in the laryngeal carcinoma, indicating the possibility that the overexpression of this protein is more specific to cancer.

Cytosolic non-specific dipeptidase 2 (CNDP2), also known as carboxypeptidase of glutamate-like (CPGL), is expressed in all human tissues [@pone.0090181-Teufel1]. Previously, Zhang et al observed that CNDP2 is downregulated in hepatocellular cancer and could inhibit the viability, colony formation, and invasion of hepatocellular carcinoma cells [@pone.0090181-Zhang2]. A recent report also demonstrated that the loss of CNDP2 functioned as a tumour suppressor gene in pancreatic cancer and that the loss of CNDP2 suppressed proliferation, induced G0/G1 accumulation, and inhibited the migration ability of a pancreatic cancer cell line [@pone.0090181-Lee1]. However, not all tumours express a low CNDP2 level, and the molecular function of CNDP2 is largely unknown. Okamura et al showed through quantitative proteomic analysis that renal cell carcinoma tissues have a high level of CNDP2 expression [@pone.0090181-Okamura1]. Tripathi et al found that CNDP2 was up-regulated in breast cancer tissues compared with normal breast epithelium [@pone.0090181-Tripathi1]. The discrepant expression of CNDP2 in different tumours may due to its tissue specificity. In consistent with the later researches, our proteomic investigation revealed the overexpression of CNDP2 in the laryngeal carcinoma, and providing the information that this protein might be an accessible biomarker for certain type of cancers.

Mimecan (OGN), a secretory protein, belongs to a family of small leucine-rich proteoglycans (SLRPs). The expression of OGN was absent in several cancer cell lines, implicating its potential role as a tumor suppressor gene in cancer biology, although its physiological function has not been fully elucidated [@pone.0090181-Wang2]. Even though, various human diseases, such as primary open-angle glaucoma and pituitary tumors, have been reported to associate with the expression of OGN [@pone.0090181-Hu1]. Concomitantly, the differential expression of this protein serves as an excellent pathological biomarker to distinguish non-small cell lung cancers from small cell lung cancers [@pone.0090181-Zheng1]. Here, our validation experiments demonstrated the significant down-expression of OGN in a large group of laryngeal carcinoma patients, hinting that OGN may be a potential tumour suppressor gene involved in laryngeal carcinoma initiation and progression.

Taken together, in this study, the use of 2D LC-MS/MS identified 281 significantly differentially expressed proteins in human laryngeal carcinoma, and four differential proteins (PFN1, NCL, CNDP2 and OGN) with expressional changes were selectively verified. It was showed that panel of the four proteins, or some of them, could serve as novel potential biomarkers for detection or therapeutic targets of human laryngeal carcinoma. Moreover, it was found that PFN1 knockdown decreased the metastasis of Hep-2 cells, demonstrating that PFN1 plays an important role in metastasis of laryngeal carcinoma. Thus, our findings reported here could have potential clinical value in diagnosis of human laryngeal carcinoma, and would provide some valuable information for further study of molecular mechanisms of this cancer.
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